论文部分内容阅读
目的:观察依达拉奉治疗脑梗死的疗效。方法:脑梗死患者60例,随机分为两组,观察组30例在内科常规治疗的基础上加用依达拉奉注射液静脉滴注,对照组30例只采用内科常规治疗。观察治疗前、后的神经功能缺损评分变化及临床疗效。结果:观察组疗效优于对照组(P<0.05),观察组治疗后的神经功能恢复优于对照组(P<0.05)。结论:依达拉奉为治疗脑梗死安全而有效的药物。
Objective: To observe the therapeutic effect of edaravone on cerebral infarction. Methods: Sixty patients with cerebral infarction were randomly divided into two groups. In the observation group, 30 cases were treated with intravenous infusion of edaravone on the basis of routine medical treatment, and 30 cases in the control group were treated by routine medical treatment. Changes of neurological deficit scores and clinical efficacy before and after treatment were observed. Results: The observation group was better than the control group (P <0.05). The recovery of neurological function in the observation group was better than that in the control group (P <0.05). Conclusion: Edaravone is a safe and effective drug for the treatment of cerebral infarction.